141 results
8-K
EX-10.1
71pq7nqq 2tu
29 Feb 24
Departure of Directors or Certain Officers
4:30pm
424B5
or46curvwccbn12rzyf
17 Jan 24
Prospectus supplement for primary offering
7:18pm
8-K
EX-10.1
d5qrci b0y5lerwao
16 Jan 24
Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
5:18pm
8-K
EX-3.1
kj16ioj945l31u
23 Oct 23
Amendments to Articles of Incorporation or Bylaws
5:01pm
8-K
EX-1.1
niq49
8 Jun 23
Vaxart, Inc. Announces Proposed Public Offering of Common Stock
4:27pm
424B5
jmangbs
8 Jun 23
Prospectus supplement for primary offering
4:17pm
424B5
r8m9po
6 Jun 23
Prospectus supplement for primary offering
5:21pm
424B5
o8z4l0x70f5vbu4ad
9 May 23
Prospectus supplement for primary offering
2:41pm
8-K
EX-99.1
ayc0q7pknksgjd8
6 Dec 22
Vaxart Announces Collaborative Funding from Leading Foundation to Study Its Norovirus Vaccine Candidate in Breastfeeding Mothers
4:21pm
8-K
y7g ku1v40
6 Dec 22
Vaxart Announces Collaborative Funding from Leading Foundation to Study Its Norovirus Vaccine Candidate in Breastfeeding Mothers
4:21pm